Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-157-5 | CAS number: 7440-47-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 3 September 1991 to 23 October 1991
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Read-across to chromium(III) oxide. The surface of chromium metal is always covered by chromium(III) oxide and therefore the results obtained with this substance can readily be used in the assessment of chromium OECD guideline study (except for one deviation). The reliablity score of 1 is given although read-across is applied. This is due to the specifi surface characteristics of chromium metal.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- (no analytical investigations on the stability of the compound of the vehicle were performed)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 84-2
- Version / remarks:
- PB 84-233295 HG-Chromo-Micronuc
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Chromium(III) oxide
- IUPAC Name:
- Chromium(III) oxide
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Strain Bor:NMRI (SPF Han), supplied by F. Winkelmann, Borchen. 30 female and 30 male mice in total.
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 29-42 g
- Assigned to test groups randomly: yes (by a randomization pland produced by the Institute of Biometrics, BAYER AG, Wuppertal)
- Fasting period before study: no data
- Housing: Females were kept in groups of maximum three mice, and males were kept singly in Makrolon type I cages. Bedding of soft wood granules, type S 8/15 (J. Rettenmaier & Söhne, Füllstoff-Fabriken, Ellwangen-Holzmühle, Germany) was used. The animals were identified by cage and picric-acid marks.
- Diet (e.g. ad libitum): Altromin 1324 Standard Diet, produced according to the specification by Alromin GmbH (ad libitum)
- Water (e.g. ad libitum): tap water ad libitum
- Acclimation period: at least one week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22.5-23 degrees Celsius
- Humidity (%): 47-54% mean relative humidity
- Air changes (per hr): about ten times per hours
- Photoperiod (hrs dark / hrs light): 12 hrs dark / 12 hrs light
IN-LIFE DATES: Sacrifice 16, 24 and 48 hours after the administration. Negative and positive controls were sacrificed after 24 hours.
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Concentration of test material in vehicle: 500 mg/ml
Due to the chemical characteristics of the compound and according to an order of the sponsor a stability test in the vehicle was not performed. - Details on exposure:
- The test substance was suspended in corn oil and injected intraperitoneally. The dose was 10000mg/kg body weight, injection volume 20 ml/kg bodyweight (= 500 mg/ml). The dose was selected based on a pilot test, in which groups of five animals were given the test substance i.p. at concentrations of 5000 mg/kg and 10000 mg/kg bodyweight. None of the animals died during the follow up period of 48 h.
- Duration of treatment / exposure:
- Single injection.
- Frequency of treatment:
- One single injection.
- Post exposure period:
- The test animals were divided into three groups, which were observed for 16, 24 or 48 hours, before sacrificed. Positive and negative control animals were sacrificed 24 hours after the injection.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
10 g/kg body weight
Basis:
nominal conc.
- No. of animals per sex per dose:
- 5 males and 5 females treated with test substance per group for each sacrifice time (16, 24 or 48 h after injection), total number 15 males and 15 females. Negative controls: 5 males and 5 females. Positive controls: 5 males and 5 females.
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Yes. 5 male and 5 female mice injected i.p. with 20 mg/kg cyclophosphamide (dissolved in deionized water) in a volume of 10 ml/kg.
Examinations
- Tissues and cell types examined:
- Erythrocytes (smears produced from at least one intact femur from each sacrificed animal). Normally, 1000 polychromatic erythrocytes were counted per animal. The number of normochromatic erythrocytes per 1000 ploychromatic ones were noted. Coated slides were evaluated using a light microscope at a magnification of about 1000. Micronuclei appeared as stained chromatin particles in the anucleated erythrocytes.
- Details of tissue and slide preparation:
CRITERIA FOR DOSE SELECTION: The dose was 10000mg/kg body weight, injection volume 20 ml/kg bodyweight (= 500 mg/ml). The dose was selected based on a pilot test, in which groups of five animals were given the test substance i.p. at concentrations of 5000 mg/kg and 10000 mg/kg bodyweight. None of the animals died during the follow up period of 48 h.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields): The test substance was suspended in corn oil and injected intraperitoneally. The test animals were divided into three groups, which were observed for 16, 24 or 48 hours, before sacrificed. Positive and negative controls were sacrificed 24 hours after the injection. The femoral marrow was prepared immediately after sacrifice.
DETAILS OF SLIDE PREPARATION: Smears were produced according to Schmid's method (Schmid, W. Mutation Res 31, 9-15, 1975). At least one intact femur was prepared from each scrificed animal. The femur was separated from muscular tissue, and the lower-leg stump was separated in the distal epiphyseal cartilage by a gentle pull at the distal end. The proximal end of the femur was opened, making visible a small opening in the bone-marrow channel. The femur was the completely immersed with in calf serum (by injection), the contents were flushed several times and the bone marrow was passed into the serum as a fine suspension. The supernatant was removed after centrifugation, and the sediment was mixed to produce a homogenous suspension. One drop of the suspension was spread on a slide, and dried overnight. The smears were stained automatically with an Ames Hema-Tek Slide Stainer (Miles Company), after which the slides were "destained" with methanol, rinsed with water and left to dry. Next the slides were transferred to a holder, immersed into acuvette filled with xylene (10 minutes) and removed. A small amount of covering agent was then applied to the coated side of the slide and covered with a glass. The slides were evaluated after the covering agent had dried.
METHOD OF ANALYSIS: The coated slides were evaluated using a light microscope at a magnification of about 1000. Micronuclei appear as stained chromatin particles in the anucleated erythrocytes, and can be distinguished from the artifacts by varying the focus. Normally 1000 polychromatic erythrocytes were calculated per animal. The incidence of cells with micronuclei was established by scanning the slides in a meandering pattern. The establishment of the polychromatic:normochromatic ratio makes it possible to identify individual animals with pathological bone-marrow dpressions, which can then be excluded from the evaluation. An alteration of the polychromatic:normochromatic ratio also provides evidence that the test substance actually has reached the target.
OTHER:- Evaluation criteria:
- If the ratio for a single animal amounts to distinctly more than 3000 normochromatic erythrocytes per 1000 polychromatic ones, without similar effects among other animals in the same group, then the case was regarded as pathological and unrelated to the treatment, and the animal was be omitted from the evaluation. A treatment-related alteration of the ratio may be concluded if it is clearly lower for the majority of the animals in the treated group than in the control group.
The data on normochromatic erythrocytes showing micronuclei permits the detection of individuals already subject to damage before the start of the test. Combined with the data on numbers of micronucleated polychromatic erythrocytes it gives an indication of the time-effect curve for positive substances.
An increase in the number of micronucleated normochromatic erythrocytes, without a preceding increase in micronucleated polychromatic erythrocytes, is irrelevant to the assessment of clastogenic effects, due to the fact that normochromatic erythrocytes originate from polychromatic ones.
A test was considered positive if there was a relevant and significant increase in the number of polychromatic erythrocytes with micronuclei in comparison with the negative controls.
A test was regarded negative if no relevant or significant increase in the rate of polychromatic erythrocytes with micronuclei was observed at any time. Tests showing significant increases in that rate, which however were within the range of negative controls (accoring to the laboratory's experience), were also considered as negative.
An unsignificant increase of micronucleated polychromatic erythrocytes above the range of historical negative controls was considered equivocal. In this case, a second test had to be performed at the most sensitive interval. - Statistics:
- The treatment group with the highest mean and the positive control were tested by Wilcoxon's non-parametric rank sum test with respect to the number of polychromatic erythrocytes having micronuclei and the number of normochromatic erythrocytes. A variation was considered statistically significant if its error probability was <5% and the treatment group figure was higher than that of the negative control.
The rate of normochromatic erythrocytes with micronuclei was examined if the rate of polychromatic erythrocytes with micronuclei was already markedly increased. The one-sided chi2-test was utilized for the comparision of the group with the highest mean with the negative controls. The criteraia for statistically significant variations were p<0.05 and a treatment group figure higher than that of the negative control.
Standard deviations were calculated for all means.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- (apathy, stretching of body, roughened fur, staggering gait, spasm and difficulty in breathing)
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
RESULTS OF RANGE-FINDING STUDY
- Dose range: 5000 mg/kg and 10000 mg/kg
- Solubility: no data
- Clinical signs of toxicity in test animals: apathy, stretching of body, roughened fur, staggering gait, spasm
- Evidence of cytotoxicity in tissue analyzed: no signs
RESULTS OF DEFINITIVE STUDY
- Treated animals showed the following toxicity symptoms until sacrifice: apathy, stretching of body, roughened fur, staggering gait, spasm and difficulty in breathing. The feeding behaviour was normal and there were no substance-induced mortlities. No symptoms were observed among the control animals.
- Induction of micronuclei (for Micronucleus assay): No significant differences in incidence of micronucleated polychromatic or normochromatic erythrocytes were observed between treatment groups and negative controls
- Ratio of PCE/NCE (for Micronucleus assay): A clear decrease in the decrease in the ratio of polychromatic to normochromatic erythrocytes was observed after treatment with the test substance. However, this ratio is not indicating any clastogenic effects, but suggests a toxic effect in the bone marrow, which may hamper the detection of micronuclei
- Appropriateness of dose levels and route: The positive control (cyclophosphamide) had a clear clastogenic effect, shown by the increased number of micronucleated polychromatic erythrocytes. The polychromatic:normochromatic erythrocyte ratio was not changed in the positive control group.
- Statistical evaluation: The test gropu with the highest mean (provided this superceded the negative control mean) and the positive control group were checked by Wilcoxon's non-parametric rank sum test with the respect to the number of polychromatic erythrocytes having micronuclei and the number of normochromatic erythrocytes. p<0.05 was considered as significant and the treatment group figure was higher than that of the negative control.
The rate of normochromatic erythrocytes containing micronuclei was examined if the micronuclear rate for polychromatic erythrocytes was already increased. The group with the highest mean was then compared with the negative control using the one-sided chi2-test. p<0.045 was considered as signifant if the treatment group figure was higher than that of the negative control.
Any other information on results incl. tables
No signs of induction of micronuclei were observed in bone marrow polychromatic erythrocytes. A clear decrease in the ratio of polychromatic to normochromatic erythrocytes was observed, which suggests a toxic effect in the bone marrow, and this may hamper the detection of micronuclei.
CHROMIUM(III) OXIDE MICRONUCLEUS TEST ON THE MOUSE | ||
Table 1 | ||
Toleration by the animals (exposure to 10000 mg/kg chromium(III) oxide i.p.) | ||
Observed symtoms | ||
Apathy | ||
Stretching of body | ||
Roughened fur | ||
Staggering gait | ||
Spasm and difficulty in breathing | ||
Feeding behaviour normal | ||
No deaths |
CHROMIUM(III) OXIDE MICRONUCLEUS TEST ON THE MOUSE | ||||
Table 2 | ||||
Toleration by the animals (exposure to 10000 mg/kg chromium(III) oxide i.p.) | ||||
Animal | No of evaluated polychromatic ethrocytes | No of normochromatic erythrocytes per 1000 polychromatic erythrocytes | Micronucleated cells per 1000 normochromatic erythrocytes | Micronucleated cells per 1000 polychromatic erythrocytes |
neg control | 10000 | 763 ± 326 | 1.4 ± 2.0 | 1.8 ± 2.0 |
test substance 16 h | 10000 | 2082 ± 843 * | 1.0 ± 0.9 | 1.1 ± 1.0 |
test substance 24 h | 10000 | 1537 ± 427 | 1.3 ± 1.1 | 1.9 ± 1.0 |
test substance 48 h | 10000 | 1497 ± 287 | 1.3 ± 0.9 | 0.6 ± 0.7 |
positive control (CP 20 mg/kg) | 10000 | 675 ± 214 | 1.8 ± 2.0 | 15.7 ± 241 * |
* p<0.01 non-parametric Wilcoxon ranking test |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
There were no indications of clastogenic effects after one intraperitoneal dose of 10000mg/kg of the test substance in mice, as detected by number of micronucleated polychromatic erythrocytes. - Executive summary:
A standard micronucleus test was carried out in mice exposed to chromium(III) oxide. Male and female NMRI mice were given a single high dose (10 g/kg body weight) of chromium(III) oxide intraperitoneally, and bone marrow samples were collected 16, 24 and 48 h after administration of the test substance. No signs of induction of micronuclei in bone marrow polychromatic erythrocytes were observed at any of the time points. However, the high dose caused some toxic symptoms. A clear decrease in the ratio of polychromatic to normochromatic erythrocytes was observed. The ratio was decreased by 63%, 50% and 51% at the 16 h, 24 h and 48 h sampling times, respectively. Such a decrease indicates a cytotoxic effect in the bone marrow, and this may hamper the detection of micronuclei.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.